Results 201 to 210 of about 318,970 (339)
The Need for Targeted Prevention and Screening in Gastrointestinal Cancer Disparities. [PDF]
Lin JC, Lin JC, Zhao J.
europepmc +1 more source
Anesthesia can alter measurements during digestive endoscopies, yet no standardized protocol currently exists. Two expert groups—the French Neuro‐Gastroenterology Group (GFNG) and anesthesiologists—used the Delphi method to reach a consensus on which drugs have an influence (91 amendments), ultimately resulting in a proposed anesthesia protocol (28 ...
Domitille Renard+29 more
wiley +1 more source
Case Report: A Novel Reconstruction Method (Itihaas's Anastomosis) for Proximal Gastrectomy. [PDF]
Sah BK, Yu Z, Li C, Zhu Z.
europepmc +1 more source
The SLR maneuver is a valuable component of GERD evaluation. By establishing optimal thresholds for both effective EGJ challenge and accurate GERD prediction, we provide another step for standardized implementation in clinical practice. ABSTRACT Background Gastroesophageal reflux disease (GERD) arises from dysfunction of the anti‐reflux barrier.
Stefano Siboni+7 more
wiley +1 more source
Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT). [PDF]
Whitehouse M.
europepmc +1 more source
Gut–brain pathways are bidirectional, but one pathway may predominate in certain disorders. The brain‐to‐gut pathway predominates in IBS, FD, and GERD, while a gut‐to‐brain disturbance dominates in overlap IBS/FD. Prior medications and gastroenteritis may indicate gut‐brain disturbances and may lead first to DGBI or GERD and later psychological ...
N. A. Koloski+4 more
wiley +1 more source
EXPERIMENTAL REFERRED PAIN FROM THE GASTRO-INTESTINAL TRACT. PART II. STOMACH, DUODENUM AND COLON [PDF]
Arthur L. Bloomfield, W. Scott Polland
openalex +1 more source
Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska+3 more
wiley +1 more source